From: Studying SARS-CoV-2 vaccine hesitancy among health professionals in Tunisia
10 | Model 1a | Model 2a | Model 3a | |||||
---|---|---|---|---|---|---|---|---|
Variables | p-value | Crude OR [95% CI] | p-value | Adjusted OR [95% CI] | p-value | Adjusted OR [95% CI] | p-value | Adjusted OR [95% CI] |
Age | 0.003 | 0.067 | 0.056 | |||||
≥ 40 years | 1 | 1 | 1 | |||||
< 40 years | 1.8 [1.2–2.6] | 1.5 [0.97–2.2] | 1.5 [0.98–2.2] | |||||
Sex | 0.047 | 0.036 | 0.013 | 0.324 | ||||
Male | - | 1 | 1 | - | 1 | 1 | ||
Female | 1.5 [1.1–2.2] | 1.6 [1.03–2.5] | 1.7 [1.1–2.7] | 1.2 [0.8–1.9] | ||||
Location of activity | 0.011 | 0.009 | 0.010 | 0.011 | ||||
North of Tunisia | - | 1 | 1 | - | 1 | 1 | ||
Central of Tunisia | 1.4 [0.9–2.1] | 1.3 [0.8–2.0] | 1.3 [0.8–2.0] | 1.3 [0.8–2.0] | ||||
Southern of Tunisia | 1.9 [1.2–3.2] | 2.3 [1.3–3.9] | 2.3 [1.3–3.9] | 2.2 [1.3–3.7] | ||||
Having been already infected by the SARS-CoV-2 | < 0.001 | < 0.001 | < 0.001 | |||||
No | - | 1 | 1 | - | 1 | |||
Yes | 0.028 [0.004–0.2] | 0.024 [0.003–0.2] | 0.024 [0.003–0.2] | |||||
Use of the national site for information about COVID-19: covid.tn | 0.005 | 0.015 | 0.010 | 0.011 | ||||
No | - | 1 | 1 | - | 1 | 1 | ||
Yes | 0.6 [0.4–0.8] | 0.6 [0.4–0.9] | 0.6 [0.4–0.9] | 0.6 [0.4–0.9] | ||||
Think that the vaccines that will be available in Tunisia may contain harmful components | 0.004 | 0.007 | 0.006 | 0.007 | ||||
No | - | 1 | 1 | - | 1 | 1 | ||
Yes | 1.8 (1.2–2.6] | 1.8 [1.2–2.7] | 1.8 [1.2–2.7] | 1.7 [1.2–2.6] | ||||
Sector of activity | 0.025 | 0.025 | ||||||
Private | 1 | 1 | ||||||
Public | 1.5 [1.1–2.3] | 1.6 [1.1–2.5] | ||||||
Frequency of direct contact with COVID-19 inpatients | 0.141 | 0.035 | ||||||
Every day | 1 | 1 | ||||||
Sometimes | 1.0 [0.6–1.7] | 1.1 [0.6–1.9] | ||||||
Never | 1.4 [0.9–2.4] | 1.8 [1.03–3.2] |